The supplemental adolescent approval enhances Solosec's strong position as the first and only single-dose oral prescription antimicrobial agent approved for the treatment of both trichomoniasis and BV.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/E9Ay8Hm
via IFTTT
0 comments:
Post a Comment